COMMUNIQUÉS West-GlobeNewswire

-
Bio-Path Holdings Announces Publication in The Lancet Haematology
29/03/2018 - 14:00 -
Spectral Announces Fourth Quarter and Fiscal 2017 Results
29/03/2018 - 14:00 -
Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC
29/03/2018 - 14:00 -
Summary of Recent Published Research on Delcath’s PHP Therapy Presented at Society of Surgical Oncology Annual Symposia
29/03/2018 - 14:00 -
CareDx Announces Completion of Debt Conversion
29/03/2018 - 14:00 -
Onsite Health Diagnostics is the first to successfully complete CLIA-Waived Laboratory Regulatory Compliance Audit performed by eTrueNorth
29/03/2018 - 14:00 -
Tyme Technologies, Inc. Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018
29/03/2018 - 14:00 -
Jeff Arnold and Dr. Mehmet Oz to Join Governor Nathan Deal for Announcement about Improving Health of Georgia Residents
29/03/2018 - 13:35 -
New Published Clinical Trial Confirms NIAGEN® Supplementation Raised Nicotinamide Adenine Dinucleotide (NAD) Levels and Potentially Improves Blood Pressure and Cardiovascular Health
29/03/2018 - 13:30 -
Evolus Reports Fourth Quarter and Full Year 2017 Financial Results
29/03/2018 - 13:30 -
Auris Regains Compliance with Nasdaq's Minimum Bid Price Requirement
29/03/2018 - 13:01 -
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
29/03/2018 - 12:30 -
MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence
29/03/2018 - 12:30 -
Ravenquest Completes Final Tranche of Non-brokered Financing
29/03/2018 - 12:00 -
Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings
29/03/2018 - 11:00 -
Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases
29/03/2018 - 09:16 -
Veritas Pharma Closes Private Placement
29/03/2018 - 09:10 -
VALNEVA to Present on Lyme and Zika at the 18th World Vaccine Congress in Washington, D.C.
29/03/2018 - 08:31 -
VALNEVA présentera sur Lyme et Zika au 18ème World Vaccine Congress de Washington, D.C.
29/03/2018 - 08:31
Pages